The International Max Planck Research School for Molecular Organ Biology (IMPRS-MOB) is excited to announce the opening of our application portal for October 2026 intake. Our innovative graduate program IMPRS-MOB is set in the vibrant Rhine-Main region, connecting three leading scientific hubs: MPI for Heart and Lung Research in Bad Nauheim, Justus Liebig University in Gießen, and Goethe University Frankfurt. Participate in an international and multidisciplinary environment that explores the cellular and molecular mechanisms controlling the physiology and pathology of organ systems.

Be part of a comprehensive three-year graduate school program encompassing lectures, specialized seminars, methods courses, and retreats. Please take full advantage of the abundant scientific resources offered by the Max Planck Institute and its associated universities. Unlock a world of opportunities as a fully funded PhD candidate!

Research projects

Successful candidates can choose an exciting research project in the field of

• Genetics
• Development
• Regeneration
• Stem Cell Biology
• Cancer
• Cardiopulmonary Research

Your profile

We are looking for creative and highly motivated candidates (f/d/m) with a strong background in biological sciences, biochemistry, medicine, pharmacy or related disciplines. It is not necessary to hold the final degree at the time of application. However, applicants should hold an excellent MSc or equivalent degree by October 2026. 

We offer

• An international and structured PhD program taught in English
• Friendly and multi-disciplinary environment
• Excellent career opportunities and working conditions
• State-of-the-art facilities and cutting-edge research projects
• Feedback, guidance and mentorship by an individual Thesis Advisory Committee
• Fully funded PhD position

We provide the perfect setting for talented scientists to jumpstart their academic careers in the vibrant field of life sciences.

Interested in joining us?

Submit your application by 31 January 2026 via our online application platform to secure your place in our 2026 cohort! Accepted candidates start no later than October 2026.